Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Restless Legs Syndrome Treatment With Botulinum Toxin [Phase 2]
A Phase 2 clinical trial evaluating botulinum toxin for restless legs syndrome has completed.
-
FDA approval · 2012-06-06FDA Approved: ROPINIROLE — Original Application (Dr. Reddys Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's generic ropinirole tablets via an original ANDA. Ropinirole is used to treat Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS [Phase 4]
The document notes the completion of a Phase IV clinical trial evaluating the effects of pramipexole on Restless Legs Syndrome symptoms and …
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances [Phase 4]
This Phase IV trial update reports the completion of a study evaluating the safety and efficacy of pramipexole for restless legs syndrome as…
-
FDA approval · 2012-05-17FDA Approved: ROPINIROLE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s original application for ropinirole, a generic formulation used to treat Parkinson's disease and res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Botulinum Toxin to Treat Restless Legs Syndrome [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated botulinum toxin for restless legs syndrome; the study is completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Bupropion and Restless Legs Syndrome [Phase 2, Phase 3]
Phase 2 and Phase 3 trial update for bupropion in restless legs syndrome with completed status and posted results.
-
FDA approval · 2012-04-02FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) [Phase 3]
A Phase 3 trial evaluating transdermal lisuride for restless legs syndrome has completed.
-
FDA approval · 2012-02-23FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for ropinirole from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2012-02-07FDA Approved: ROPINIROLE — Original Application (Marlex Pharmaceuticals Inc)
FDA approved a generic version of ropinirole (Original Application) by Marlex Pharmaceuticals Inc for use in Parkinson's disease and restles…
-
FDA label_change · 2011-10-31FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for ropinirole from Alembic Pharmaceuticals Limited, indicating an update to the product labelin…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome [Phase 2]
A Phase 2 clinical trial evaluating the effects of Aplindore on signs and symptoms of Restless Legs Syndrome has completed. The study was sp…
-
FDA approval · 2011-08-29FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for a generic pramipexole dihydrochloride product from Torrent Pharmaceuticals Limited, for the trea…
-
FDA approval · 2011-08-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride submitted by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean [NA]
A completed clinical trial sponsored by Nanjing Medical University evaluated neuraxial anesthesia in cesarean deliveries and its relation to…
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Simulated Driving Study in Restless Legs Syndrome [Phase 2]
Results from a Phase 2 simulated driving study in Restless Legs Syndrome sponsored by XenoPort have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) [Phase 2]
Phase 2 trial of IV iron preparation VIT-45 for Restless Legs Syndrome has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome. [Phase 3]
Extension phase 3 trial of XP13512 (gabapentin enacarbil) in patients with Restless Legs Syndrome; the study has completed and results were …
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating vitamin C, vitamin E, and their combination for restless legs syndrome in patients on hemodialysis; the study has…
-
CLINICAL_TRIALS trial_result · 2011-06-13Clinical Trial Update: Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) [Phase 2]
Phase 2 clinical trial evaluating immediate-release ropinirole for restless legs syndrome in patients with chronic kidney disease on haemodi…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome [Phase 2]
Phase 2 study assessing dose-response and pharmacokinetics of gabapentin enacarbil for restless legs syndrome.
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome. [Phase 3]
A long-term Phase 3 study comparing gabapentin enacarbil to placebo in patients with Restless Legs Syndrome has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance [Phase 3]
Phase 3 randomized, placebo-controlled study evaluating extended-release GSK1838262 for Restless Legs Syndrome and associated sleep disturba…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole [Phase 4]
A Phase 4 clinical trial update reports Restless Legs Syndrome patients switching from pramipexole to ropinirole. The study examines outcome…